D
Denali Therapeutics Inc. DNLI
$15.15 $0.261.75%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -114.75M -107.19M -99.03M -101.80M -119.47M
Total Depreciation and Amortization -5.28M 2.27M 1.94M 2.16M 2.18M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 25.76M 15.43M 14.02M 1.83M 12.79M
Change in Net Operating Assets 10.56M 30.35M -8.16M -15.81M 5.85M
Cash from Operations -83.72M -59.14M -91.22M -113.62M -98.66M
Capital Expenditure -5.09M -3.88M -4.79M -2.15M -2.24M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 177.30M 97.54M 103.36M -451.04M 75.28M
Cash from Investing 172.21M 93.66M 98.57M -453.19M 73.05M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -8.32M -24.02M -- -- --
Issuance of Common Stock 4.16M 5.94M 6.76M 500.28M 4.71M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 0.00 -480.00K -- -- --
Cash from Financing -4.17M -18.56M 6.76M 500.28M 4.71M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 84.32M 15.96M 14.11M -66.53M -20.91M
Weiss Ratings